share_log

Guggenheim Upgrades Medpace Hldgs to Buy, Announces $252 Price Target

Benzinga ·  May 8, 2023 09:37

Guggenheim analyst Sandy Draper upgrades Medpace Hldgs (NASDAQ:MEDP) from Neutral to Buy and announces $252 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment